Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, s… Read more
Granules India Limited (GRANULES) - Total Liabilities
Latest total liabilities as of September 2025: ₹29.61 Billion INR
Based on the latest financial reports, Granules India Limited (GRANULES) has total liabilities worth ₹29.61 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Granules India Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Granules India Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Granules India Limited Competitors by Total Liabilities
The table below lists competitors of Granules India Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
HuBei SanFeng Intelligent Conveying Equipment Co Ltd
SHE:300276
|
China | CN¥2.29 Billion |
|
Asian Star Anchor Chain Co Ltd Jiangsu
SHG:601890
|
China | CN¥1.61 Billion |
|
Retail Estates N.V.
LSE:0FSO
|
UK | €962.43 Million |
|
China Resources Pharmaceutical Group Limited
F:640
|
Germany | €174.81 Billion |
|
Jiangsu Baichuan HighTech New Materials Co Ltd
SHE:002455
|
China | CN¥10.20 Billion |
|
Luoniushan Co Ltd
SHE:000735
|
China | CN¥5.42 Billion |
|
Green Thumb Industries Inc
OTCQX:GTBIF
|
USA | $804.27 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Granules India Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.26 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Granules India Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Granules India Limited (2006–2025)
The table below shows the annual total liabilities of Granules India Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹25.37 Billion | +10.52% |
| 2024-03-31 | ₹22.95 Billion | +10.91% |
| 2023-03-31 | ₹20.70 Billion | +7.47% |
| 2022-03-31 | ₹19.26 Billion | +25.04% |
| 2021-03-31 | ₹15.40 Billion | +5.65% |
| 2020-03-31 | ₹14.58 Billion | +0.31% |
| 2019-03-31 | ₹14.53 Billion | +8.48% |
| 2018-03-31 | ₹13.40 Billion | +37.71% |
| 2017-03-31 | ₹9.73 Billion | +23.64% |
| 2016-03-31 | ₹7.87 Billion | +2.72% |
| 2015-03-31 | ₹7.66 Billion | +20.43% |
| 2014-03-31 | ₹6.36 Billion | +55.94% |
| 2013-03-31 | ₹4.08 Billion | +25.03% |
| 2012-03-31 | ₹3.26 Billion | +51.67% |
| 2011-03-31 | ₹2.15 Billion | +2.62% |
| 2010-03-31 | ₹2.10 Billion | -8.81% |
| 2009-03-31 | ₹2.30 Billion | +15.85% |
| 2008-03-31 | ₹1.98 Billion | +21.87% |
| 2007-03-31 | ₹1.63 Billion | +15.15% |
| 2006-03-31 | ₹1.41 Billion | -- |